EQ-300 INTEX PHARMA

£65.00

EQ-300 Intex Pharma is a pharmaceutical-grade boldenone undecylenate solution designed for in-vitro research investigations into anabolic steroid mechanisms and tissue selectivity studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
EQ-300 INTEX PHARMA
EQ-300 INTEX PHARMA
£65.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

EQ-300 INTEX PHARMA: Compound Profile

EQ-300 Intex Pharma is a pharmaceutical-grade boldenone undecylenate injectable solution formulated specifically for laboratory research applications. Boldenone undecylenate is an anabolic-androgenic steroid derived from testosterone, characterised by its unique double bond modification at the 1,2 position and long-acting undecylenate ester attachment. Research scientists investigating anabolic steroid pharmacology frequently examine this compound for its distinctive anabolic-to-androgenic ratio and extended half-life properties. The compound demonstrates reduced aromatisation compared to testosterone in preclinical studies, making it valuable for research into selective tissue targeting mechanisms.

As a trusted research chemical supplier, Stroid UK Shop provides this laboratory-grade material to support academic and commercial research institutions. Scientists studying comparative steroid pharmacokinetics often investigate EQ-300 alongside compounds available in our comprehensive Equipoise research collection. Researchers examining broader anabolic mechanisms may also reference studies involving selective androgen receptor modulators and growth-promoting peptides for comparative analysis protocols.

Research Applications

Laboratory investigations utilising EQ-300 typically focus on anabolic steroid receptor binding kinetics, tissue distribution studies, and metabolic pathway analysis. The compound’s extended pharmacokinetic profile enables researchers to study sustained anabolic activity patterns in controlled experimental settings. Cell culture studies examine boldenone’s interaction with androgen receptor subtypes, while tissue selectivity research investigates its preferential effects on muscle versus prostate tissue in animal models. Metabolic researchers analyse the compound’s effects on nitrogen retention, protein synthesis pathways, and erythropoietin stimulation mechanisms.

Comparative pharmacology studies frequently examine EQ-300’s aromatisation characteristics alongside other anabolic compounds, providing insights into estrogen-mediated side effect profiles. Analytical chemistry laboratories utilise this reference material for developing detection methodologies and studying metabolite formation patterns. Research into anabolic steroid structure-activity relationships often incorporates boldenone undecylenate as a key comparative compound due to its modified steroid backbone and unique pharmacological properties.

Technical Specifications

EQ-300 Research Specifications
Parameter Value
Active Compound Boldenone Undecylenate
Concentration 300mg/ml
Chemical Formula C₃₀H₄₄O₃
Molecular Weight 452.67 g/mol
Manufacturer Intex Pharma
Research Grade Pharmaceutical
Storage Requirements Room temperature, protect from light
Shelf Life 3 years unopened

Research Compliance

This product is manufactured exclusively for in-vitro research purposes and laboratory investigations. EQ-300 Intex Pharma is not intended for human consumption, therapeutic use, or any applications outside controlled research environments. All research must comply with relevant institutional guidelines and regulatory requirements. Users must maintain proper laboratory safety protocols and waste disposal procedures when handling this research chemical.

Related